This work aims to provide a systematic and updated survey of original scientific studies on
the effect of the introduction of reference pricing (RP) policies in Organisation for Economic …

The cost of drugs is a major and rapidly rising component of health-care expenditures. We
survey recent literature on the ethics and economics of skyrocketing pharmaceutical prices …

Background: With the exception of Canada, all countries with universal health insurance
systems provide universal coverage of prescription drugs. Progress toward universal public …

Objectives The aim of this review is to assess the current state of empirical research
regarding the effectiveness of national pricing regulations of the patent-protected market for …

Abstract despite Canadians' pride in medicare and the values underpinning it, the system is
conspicuously incomplete. universal public health insurance in Canada ends as soon as a …

Canada needs a national strategy to fulfill its obligation to ensure universal access to
necessary healthcare, including prescription drugs. A 2004 attempt at a national strategy for …

With" Big Pharma" garnering an increasing number of negative headlines due to reports of
adverse drug reactions and a surge in prescription drug addiction and overdose deaths …

Background Sex and gender sensitive inquiry is critical in pharmaceutical policy due to the
sector's historical connection with women's health issues and due to the confluence of …

OBJECTIVES: Changes in the traditional model of drug development are creating a potential
opportunity for New Zealand's drug development industry. This research evaluates whether …

Health policy-makers worldwide have adopted different Reference Pricing (RP) systems for
pharmaceuticals. Systems may differ concerning their effects on pharmaceutical prices …